메뉴 건너뛰기




Volumn 61, Issue 5, 2006, Pages 518-526

Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma

Author keywords

Ciclesonide; Cough; Dysphonia; Oropharyngeal candidiasis; Pharyngitis

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLXANTHINE DERIVATIVE; NEDOCROMIL; OMALIZUMAB; TRIAMCINOLONE ACETONIDE;

EID: 33745284283     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01090.x     Document Type: Review
Times cited : (105)

References (75)
  • 1
    • 0037122408 scopus 로고    scopus 로고
    • Treatment of allergic asthma
    • Lin H Casale TB. Treatment of allergic asthma. Am J Med 2002 113 ( Suppl. 9A 8S 16S.
    • (2002) Am J Med , vol.113 , Issue.9
    • Lin, H.1    Casale, T.B.2
  • 6
    • 0346041503 scopus 로고    scopus 로고
    • Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation
    • Miranda C Busacker A Balzar S Trudeau J Wenzel SE. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004 113 : 101 108.
    • (2004) J Allergy Clin Immunol , vol.113 , pp. 101-108
    • Miranda, C.1    Busacker, A.2    Balzar, S.3    Trudeau, J.4    Wenzel, S.E.5
  • 7
    • 0036675911 scopus 로고    scopus 로고
    • Environmental contributions to the allergic asthma epidemic
    • Kheradmand F Rishi K Corry DB. Environmental contributions to the allergic asthma epidemic. Environ Health Perspect 2002 110 ( Suppl. 4 553 556.
    • (2002) Environ Health Perspect , vol.110 , Issue.4 , pp. 553-556
    • Kheradmand, F.1    Rishi, K.2    Corry, D.B.3
  • 8
    • 33745250530 scopus 로고    scopus 로고
    • World Health Organization. (Accessed October 24, 2005) M.*Fabian D.*Holt S.*Beasley R. (Accessed October 25, 2005).
    • World Health Organization. Fact sheet 206. Bronchial asthma. 2000. http://www.who.int/mediacentre/factsheets/fs206/en/print.html (Accessed October 24, 2005) M Fabian D Holt S Beasley R. Global burden of asthma. 2004. http://www.ginasthma.com/ReportItem.asp?l1=2&l2=2 (Accessed October 25, 2005).
    • (2000) Global Burden of Asthma
  • 9
    • 2342590065 scopus 로고    scopus 로고
    • The global burden of asthma: Executive summary of the GINA Dissemination Committee report
    • Masoli M Fabian D Holt S Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004 59 : 469 478.
    • (2004) Allergy , vol.59 , pp. 469-478
    • Masoli, M.1    Fabian, D.2    Holt, S.3    Beasley, R.4
  • 10
    • 0346236998 scopus 로고    scopus 로고
    • American Lung Association. January. Table 13: Economic cost of asthma, direct medical and indirect expenditures, US 2002.. Accessed on October 25, 2005.
    • American Lung Association. Trends in asthma morbidity and mortality, January 2003. Table 13: Economic cost of asthma, direct medical and indirect expenditures, US 2002. http://www.lungusa.org/site/pp.asp?c=dvLUK9O0E&b= 22884. Accessed on October 25, 2005.
    • (2003) Trends in Asthma Morbidity and Mortality
  • 12
    • 0033799456 scopus 로고    scopus 로고
    • Molecular basis for corticosteroid action in asthma
    • Barnes PJ. Molecular basis for corticosteroid action in asthma. Chem Immunol 2000 78 : 72 80.
    • (2000) Chem Immunol , vol.78 , pp. 72-80
    • Barnes, P.J.1
  • 13
    • 0032905475 scopus 로고    scopus 로고
    • The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma
    • Georgitis JW. The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma. Chest 1999 115 : 210 217.
    • (1999) Chest , vol.115 , pp. 210-217
    • Georgitis, J.W.1
  • 14
    • 0042235397 scopus 로고    scopus 로고
    • Potential adverse effects of the inhaled corticosteroids
    • Kelly HW Nelson HS. Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol 2003 112 : 469 478.
    • (2003) J Allergy Clin Immunol , vol.112 , pp. 469-478
    • Kelly, H.W.1    Nelson, H.S.2
  • 15
    • 0028889036 scopus 로고
    • Adverse effects of inhaled corticosteroids
    • Hanania NA Chapman KR Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 1995 98 : 196 208.
    • (1995) Am J Med , vol.98 , pp. 196-208
    • Hanania, N.A.1    Chapman, K.R.2    Kesten, S.3
  • 16
    • 3242734980 scopus 로고    scopus 로고
    • The local side effects of inhaled corticosteroids: Current understanding and review of the literature
    • Roland NJ Bhalla RK Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 2004 126 : 213 219.
    • (2004) Chest , vol.126 , pp. 213-219
    • Roland, N.J.1    Bhalla, R.K.2    Earis, J.3
  • 18
    • 0035117761 scopus 로고    scopus 로고
    • The influence of lung deposition on clinical response
    • Pritchard JN. The influence of lung deposition on clinical response. J Aerosol Med 2001 14 ( Suppl. 1 S19 S26.
    • (2001) J Aerosol Med , vol.14 , Issue.1
    • Pritchard, J.N.1
  • 19
    • 0028889728 scopus 로고
    • The Diskus: A new multi-dose powder device - Efficacy and comparison with Turbuhaler
    • Fuller R. The Diskus: a new multi-dose powder device - efficacy and comparison with Turbuhaler. J Aerosol Med 1995 8 ( Suppl. 2 S11 S17.
    • (1995) J Aerosol Med , vol.8 , Issue.2
    • Fuller, R.1
  • 20
    • 0032866032 scopus 로고    scopus 로고
    • Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma
    • Agertoft L Pedersen S Nikander K. Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma. J Aerosol Med 1999 12 : 161 169.
    • (1999) J Aerosol Med , vol.12 , pp. 161-169
    • Agertoft, L.1    Pedersen, S.2    Nikander, K.3
  • 21
    • 0036036475 scopus 로고    scopus 로고
    • Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: A cross-over study in healthy volunteers
    • Leach CL Davidson PJ Hasselquist BE Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest 2002 122 : 510 516.
    • (2002) Chest , vol.122 , pp. 510-516
    • Leach, C.L.1    Davidson, P.J.2    Hasselquist, B.E.3    Boudreau, R.J.4
  • 22
    • 1542559715 scopus 로고    scopus 로고
    • PK/PD of inhaled corticosteroids: The risk/benefit of inhaled ciclesonide [abstract]
    • Abstract 598.
    • Rohatagi S Derendorf H Zech K Nave R Banerji D. PK/PD of inhaled corticosteroids: the risk/benefit of inhaled ciclesonide [abstract]. J Allergy Clin Immunol 2003 111 ( Suppl. S218, Abstract 598.
    • (2003) J Allergy Clin Immunol , vol.111
    • Rohatagi, S.1    Derendorf, H.2    Zech, K.3    Nave, R.4    Banerji, D.5
  • 25
    • 0032438394 scopus 로고    scopus 로고
    • Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone
    • Leach CL Davidson PJ Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998 12 : 1346 1353.
    • (1998) Eur Respir J , vol.12 , pp. 1346-1353
    • Leach, C.L.1    Davidson, P.J.2    Boudreau, R.J.3
  • 26
    • 0027986957 scopus 로고
    • Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI
    • Thorsson L Edsbacker S Conradson TB. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J 1994 7 : 1839 1844.
    • (1994) Eur Respir J , vol.7 , pp. 1839-1844
    • Thorsson, L.1    Edsbacker, S.2    Conradson, T.B.3
  • 27
    • 0030014246 scopus 로고    scopus 로고
    • A 1-year comparison of Turbuhaler vs pressurized metered-dose inhaler in asthmatic patients
    • Pauwels RA Hargreave FE Camus P Bukoski M Stahl E. A 1-year comparison of Turbuhaler vs pressurized metered-dose inhaler in asthmatic patients. Chest 1996 110 : 53 57.
    • (1996) Chest , vol.110 , pp. 53-57
    • Pauwels, R.A.1    Hargreave, F.E.2    Camus, P.3    Bukoski, M.4    Stahl, E.5
  • 28
    • 0032589989 scopus 로고    scopus 로고
    • Inhaled and nasal corticosteroids: Factors affecting the risks of systemic adverse effects
    • Cave A Arlett P Lee E. Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects. Pharmacol Ther 1999 83 : 153 179.
    • (1999) Pharmacol Ther , vol.83 , pp. 153-179
    • Cave, A.1    Arlett, P.2    Lee, E.3
  • 29
    • 2342667615 scopus 로고    scopus 로고
    • Spacer devices for metered dose inhalers
    • Newman SP. Spacer devices for metered dose inhalers. Clin Pharmacokinet 2004 43 : 349 360.
    • (2004) Clin Pharmacokinet , vol.43 , pp. 349-360
    • Newman, S.P.1
  • 30
    • 0025951893 scopus 로고
    • Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique
    • Newman SP Weisz AW Talaee N Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991 46 : 712 716.
    • (1991) Thorax , vol.46 , pp. 712-716
    • Newman, S.P.1    Weisz, A.W.2    Talaee, N.3    Clarke, S.W.4
  • 31
    • 84991138982 scopus 로고
    • Comparison of conventional metered dose inhaler and breath actuated inhaler in elderly patients
    • Hendry A Coote J Black H Duncan G MacDonald JB. Comparison of conventional metered dose inhaler and breath actuated inhaler in elderly patients. Int J Pharm Pract 1995 3 : 115 118.
    • (1995) Int J Pharm Pract , vol.3 , pp. 115-118
    • Hendry, A.1    Coote, J.2    Black, H.3    Duncan, G.4    MacDonald, J.B.5
  • 32
    • 0030906433 scopus 로고    scopus 로고
    • Competence thresholds for the use of inhalers in people with dementia
    • Allen SC. Competence thresholds for the use of inhalers in people with dementia. Age Ageing 1997 26 : 83 86.
    • (1997) Age Ageing , vol.26 , pp. 83-86
    • Allen, S.C.1
  • 33
    • 0022449830 scopus 로고
    • Errors in inhalation technique and efficiency in inhaler use in asthmatic children
    • Pedersen S Frost L Arnfred T. Errors in inhalation technique and efficiency in inhaler use in asthmatic children. Allergy 1986 41 : 118 124.
    • (1986) Allergy , vol.41 , pp. 118-124
    • Pedersen, S.1    Frost, L.2    Arnfred, T.3
  • 34
    • 0029010454 scopus 로고
    • Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations
    • Williamson IJ Matusiewicz SP Brown PH Greening AP Crompton GK. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J 1995 8 : 590 592.
    • (1995) Eur Respir J , vol.8 , pp. 590-592
    • Williamson, I.J.1    Matusiewicz, S.P.2    Brown, P.H.3    Greening, A.P.4    Crompton, G.K.5
  • 35
    • 0034847405 scopus 로고    scopus 로고
    • Local side-effects of inhaled corticosteroids in asthmatic children: Influence of drug, dose, age, and device
    • Dubus JC Marguet C Deschildre A Mely L Le Roux P Brouard J et al. Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device. Allergy 2001 56 : 944 948.
    • (2001) Allergy , vol.56 , pp. 944-948
    • Dubus, J.C.1    Marguet, C.2    Deschildre, A.3    Mely, L.4    Le Roux, P.5    Brouard, J.6
  • 38
    • 11144349963 scopus 로고    scopus 로고
    • Low incidence of oropharyngeal adverse events in asthma patients treated with ciclesonide: Results from a pooled analysis [abstract]
    • Abstract
    • Engelstätter R Banerji D Steinijans VW Wurst W. Low incidence of oropharyngeal adverse events in asthma patients treated with ciclesonide: results from a pooled analysis [abstract]. Am J Respir Crit Care Med 2004 169 ( Suppl. Abstract A92.
    • (2004) Am J Respir Crit Care Med , vol.169
    • Engelstätter, R.1    Banerji, D.2    Steinijans, V.W.3    Wurst, W.4
  • 39
    • 0028874693 scopus 로고
    • Hypertrophy of the tongue associated with inhaled corticosteroid therapy in premature infants
    • Linder N Kuint J German B Lubin D Loewenthal R. Hypertrophy of the tongue associated with inhaled corticosteroid therapy in premature infants. J Pediatr 1995 127 : 651 653.
    • (1995) J Pediatr , vol.127 , pp. 651-653
    • Linder, N.1    Kuint, J.2    German, B.3    Lubin, D.4    Loewenthal, R.5
  • 40
    • 0034897331 scopus 로고    scopus 로고
    • Inhalational and topical steroids, and oral candidosis: A mini review
    • Ellepola AN Samaranayake LP. Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis 2001 7 : 211 216.
    • (2001) Oral Dis , vol.7 , pp. 211-216
    • Ellepola, A.N.1    Samaranayake, L.P.2
  • 42
    • 0036668764 scopus 로고    scopus 로고
    • Distinct protective host defenses against oral and vaginal candidiasis
    • Fidel PL Jr.. Distinct protective host defenses against oral and vaginal candidiasis. Med Mycol 2002 40 : 359 375.
    • (2002) Med Mycol , vol.40 , pp. 359-375
    • Fidel Jr., P.L.1
  • 43
    • 0025096776 scopus 로고
    • Complications of topical steroid therapy for asthma
    • Toogood JH. Complications of topical steroid therapy for asthma. Am Rev Respir Dis 1990 141 : S89 S96.
    • (1990) Am Rev Respir Dis , vol.141
    • Toogood, J.H.1
  • 44
    • 0015050349 scopus 로고
    • Growth of Candida albicans in saliva: Stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus
    • Knight L Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J Infect Dis 1971 123 : 371 377.
    • (1971) J Infect Dis , vol.123 , pp. 371-377
    • Knight, L.1    Fletcher, J.2
  • 45
    • 0018569368 scopus 로고
    • The incidence of oral candidiasis with use of inhaled corticosteroids
    • Vogt FC. The incidence of oral candidiasis with use of inhaled corticosteroids. Ann Allergy 1979 43 : 205 210.
    • (1979) Ann Allergy , vol.43 , pp. 205-210
    • Vogt, F.C.1
  • 46
    • 0022461284 scopus 로고
    • Inhaled beclomethasone and oral candidiasis
    • Shaw NJ Edmunds AT. Inhaled beclomethasone and oral candidiasis. Arch Dis Child 1986 61 : 788 790.
    • (1986) Arch Dis Child , vol.61 , pp. 788-790
    • Shaw, N.J.1    Edmunds, A.T.2
  • 47
    • 0023838780 scopus 로고
    • Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber
    • Salzman GA Pyszczynski DR. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. J Allergy Clin Immunol 1988 81 : 424 428.
    • (1988) J Allergy Clin Immunol , vol.81 , pp. 424-428
    • Salzman, G.A.1    Pyszczynski, D.R.2
  • 48
  • 49
    • 0033866555 scopus 로고    scopus 로고
    • Occurrence and risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids
    • Kennedy WA Laurier C Gautrin D Ghezzo H Pare M Malo JL et al. Occurrence and risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids. J Clin Epidemiol 2000 53 : 696 701.
    • (2000) J Clin Epidemiol , vol.53 , pp. 696-701
    • Kennedy, W.A.1    Laurier, C.2    Gautrin, D.3    Ghezzo, H.4    Pare, M.5    Malo, J.L.6
  • 51
    • 0038516811 scopus 로고    scopus 로고
    • Oral candidiasis associated with inhaled corticosteroid use: Comparison of fluticasone and beclomethasone
    • Fukushima C Matsuse H Tomari S Obase Y Miyazaki Y Shimoda T et al. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003 90 : 646 651.
    • (2003) Ann Allergy Asthma Immunol , vol.90 , pp. 646-651
    • Fukushima, C.1    Matsuse, H.2    Tomari, S.3    Obase, Y.4    Miyazaki, Y.5    Shimoda, T.6
  • 53
    • 0034755619 scopus 로고    scopus 로고
    • Effects of amphotericin B gargles on oral colonization of Candida albicans in asthmatic patients on steroid inhalation therapy
    • Fukushima C Shimoda T Kawano T Tomari S Mitsuta K Obase Y et al. Effects of amphotericin B gargles on oral colonization of Candida albicans in asthmatic patients on steroid inhalation therapy. Respiration 2001 68 : 465 470.
    • (2001) Respiration , vol.68 , pp. 465-470
    • Fukushima, C.1    Shimoda, T.2    Kawano, T.3    Tomari, S.4    Mitsuta, K.5    Obase, Y.6
  • 54
    • 0031840790 scopus 로고    scopus 로고
    • Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide
    • Agertoft L Larsen FE Pedersen S. Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide. Eur Respir J 1998 12 : 130 135.
    • (1998) Eur Respir J , vol.12 , pp. 130-135
    • Agertoft, L.1    Larsen, F.E.2    Pedersen, S.3
  • 55
    • 0027162055 scopus 로고
    • Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group
    • Fabbri L Burge PS Croonenborgh L Warlies F Weeke B Ciaccia A et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax 1993 48 : 817 823.
    • (1993) Thorax , vol.48 , pp. 817-823
    • Fabbri, L.1    Burge, P.S.2    Croonenborgh, L.3    Warlies, F.4    Weeke, B.5    Ciaccia, A.6
  • 56
    • 0029075287 scopus 로고
    • High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group
    • Ayres JG Bateman ED Lundback B Harris TA. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group. Eur Respir J 1995 8 : 579 586.
    • (1995) Eur Respir J , vol.8 , pp. 579-586
    • Ayres, J.G.1    Bateman, E.D.2    Lundback, B.3    Harris, T.A.4
  • 57
    • 0028567324 scopus 로고
    • Local side-effects during 4-year treatment with inhaled corticosteroids - A comparison between pressurized metered-dose inhalers and Turbuhaler
    • Selroos O Backman R Forsen KO Lofroos AB Niemisto M Pietinalho A et al. Local side-effects during 4-year treatment with inhaled corticosteroids - a comparison between pressurized metered-dose inhalers and Turbuhaler. Allergy 1994 49 : 888 890.
    • (1994) Allergy , vol.49 , pp. 888-890
    • Selroos, O.1    Backman, R.2    Forsen, K.O.3    Lofroos, A.B.4    Niemisto, M.5    Pietinalho, A.6
  • 59
    • 0033625659 scopus 로고    scopus 로고
    • Comparison of Pulmicort pMDI plus Nebuhaler and Pulmicort Turbuhaler in asthmatic patients with dysphonia
    • Crompton GK Sanderson R Dewar MH Matusiewicz SP Ning AC Jamieson AH et al. Comparison of Pulmicort pMDI plus Nebuhaler and Pulmicort Turbuhaler in asthmatic patients with dysphonia. Respir Med 2000 94 : 448 453.
    • (2000) Respir Med , vol.94 , pp. 448-453
    • Crompton, G.K.1    Sanderson, R.2    Dewar, M.H.3    Matusiewicz, S.P.4    Ning, A.C.5    Jamieson, A.H.6
  • 60
    • 0033635738 scopus 로고    scopus 로고
    • Dysphonia associated with inhaled steroids
    • Lavy JA Wood G Rubin JS Harries M. Dysphonia associated with inhaled steroids. J Voice 2000 14 : 581 588.
    • (2000) J Voice , vol.14 , pp. 581-588
    • Lavy, J.A.1    Wood, G.2    Rubin, J.S.3    Harries, M.4
  • 61
    • 0038547757 scopus 로고    scopus 로고
    • Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma
    • Tinkelman DG Bronsky EA Gross G Schoenwetter WF Spector SL. Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma. J Asthma 2003 40 : 225 236.
    • (2003) J Asthma , vol.40 , pp. 225-236
    • Tinkelman, D.G.1    Bronsky, E.A.2    Gross, G.3    Schoenwetter, W.F.4    Spector, S.L.5
  • 62
    • 0034886238 scopus 로고    scopus 로고
    • Inhaled mometasone furoate: A review of its use in adults and adolescents with persistent asthma
    • Sharpe M Jarvis B. Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma. Drugs 2001 61 : 1325 1350.
    • (2001) Drugs , vol.61 , pp. 1325-1350
    • Sharpe, M.1    Jarvis, B.2
  • 63
    • 84928701208 scopus 로고    scopus 로고
    • Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma
    • CD002310 DH Pepys J. Bronchial reactions to aerosol inhalant vehicle. Br Med J 1976 1 : 1319 1320.
    • Adams N Bestall JM Lasserson TJ Jones PW. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma. Cochrane Database Syst Rev 2004 2 : CD002310 DH Pepys J. Bronchial reactions to aerosol inhalant vehicle. Br Med J 1976 1 : 1319 1320.
    • (2004) Cochrane Database Syst Rev , vol.2 , pp. 1319-1320
    • Adams, N.1    Bestall, J.M.2    Lasserson, T.J.3    Jones, P.W.4
  • 64
    • 0023236864 scopus 로고
    • Cough and wheezing from beclomethasone dipropionate aerosol are absent after triamcinolone acetonide
    • Shim CS Williams MH Jr.. Cough and wheezing from beclomethasone dipropionate aerosol are absent after triamcinolone acetonide. Ann Intern Med 1987 106 : 700 703.
    • (1987) Ann Intern Med , vol.106 , pp. 700-703
    • Shim, C.S.1    Williams Jr., M.H.2
  • 65
    • 0141705348 scopus 로고    scopus 로고
    • Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma
    • Dubus JC Mely L Huiart L Marguet C Le Roux P. Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma. Fundam Clin Pharmacol 2003 17 : 627 631.
    • (2003) Fundam Clin Pharmacol , vol.17 , pp. 627-631
    • Dubus, J.C.1    Mely, L.2    Huiart, L.3    Marguet, C.4    Le Roux, P.5
  • 66
    • 0345733708 scopus 로고    scopus 로고
    • Risk-benefit value of inhaled glucocorticoids: A pharmacokinetic/ pharmacodynamic perspective
    • Rohatagi S Appajosyula S Derendorf H Szefler S Nave R Zech K et al. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective. J Clin Pharmacol 2004 44 : 37 47.
    • (2004) J Clin Pharmacol , vol.44 , pp. 37-47
    • Rohatagi, S.1    Appajosyula, S.2    Derendorf, H.3    Szefler, S.4    Nave, R.5    Zech, K.6
  • 67
    • 5444253912 scopus 로고    scopus 로고
    • Ciclesonide: A novel inhaled corticosteroid
    • Humbert M. Ciclesonide: a novel inhaled corticosteroid. Expert Opin Investig Drugs 2004 13 : 1349 1360.
    • (2004) Expert Opin Investig Drugs , vol.13 , pp. 1349-1360
    • Humbert, M.1
  • 69
    • 0035985611 scopus 로고    scopus 로고
    • Ciclesonide (Byk Gulden)
    • Dent G. Ciclesonide (Byk Gulden). Curr Opin Investig Drugs 2002 3 : 78 83.
    • (2002) Curr Opin Investig Drugs , vol.3 , pp. 78-83
    • Dent, G.1
  • 71
    • 1542664674 scopus 로고    scopus 로고
    • Ciclesonide shows high lung deposition in 2D and 3D-imaging [abstract]
    • Abstract A40.
    • Drollmann A Hasselquist BE Boudreau RJ. Ciclesonide shows high lung deposition in 2D and 3D-imaging [abstract]. Am J Respir Crit Care Med 2002 165 : A188, Abstract A40.
    • (2002) Am J Respir Crit Care Med , vol.165
    • Drollmann, A.1    Hasselquist, B.E.2    Boudreau, R.J.3
  • 72
    • 32644435870 scopus 로고    scopus 로고
    • 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma
    • 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma. Respir Med 2005 100 : 375 384.
    • (2005) Respir Med , vol.100 , pp. 375-384
    • Newman, S.1    Salmon, A.2    Nave, R.3    Drollmann, A.4
  • 73
    • 20044369411 scopus 로고    scopus 로고
    • Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects
    • Nave R Zech K Bethke TD. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects. Eur J Clin Pharmacol 2005 61 : 203 208.
    • (2005) Eur J Clin Pharmacol , vol.61 , pp. 203-208
    • Nave, R.1    Zech, K.2    Bethke, T.D.3
  • 74
    • 16244397682 scopus 로고    scopus 로고
    • Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma
    • Richter K Kanniess F Biberger C Nave R Magnussen H. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma. J Clin Pharmacol 2005 45 : 146 152.
    • (2005) J Clin Pharmacol , vol.45 , pp. 146-152
    • Richter, K.1    Kanniess, F.2    Biberger, C.3    Nave, R.4    Magnussen, H.5
  • 75
    • 20944444681 scopus 로고    scopus 로고
    • Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma
    • Lipworth BJ Kaliner MA LaForce CF Baker JW Kaiser HB Amin D et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol 2005 94 : 465 472.
    • (2005) Ann Allergy Asthma Immunol , vol.94 , pp. 465-472
    • Lipworth, B.J.1    Kaliner, M.A.2    Laforce, C.F.3    Baker, J.W.4    Kaiser, H.B.5    Amin, D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.